 New York, New York--Newsfile Corp. - August 9, 2021 - Bronstein, Gewirtz Grossman, LLC notifies investors that a class action lawsuit has been filed against AcelRx Pharmaceuticals, Inc. AcelRx or the Company NASDAQ: ACRX and certain of its officers, on behalf of shareholders who purchased or otherwise acquired AcelRx securities between March 17, 2020 and February 12, 2021, the Class Period. Such investors are encouraged to join this case by visiting the firms site:... 